Evidence map›Paper›PMID 31159853›Full record

ArticleBMC medical ethics2019

Huge variation in obtaining ethical permission for a non-interventional observational study in Europe.

Dylan W de Lange, Bertrand Guidet, Finn H Andersen, Antonio Artigas, Guidio Bertolini, Rui Moreno, Steffen Christensen, Maurizio Cecconi, Christina Agvald-Ohman, Primoz Gradisek and 8 more

Abstract read
In one paragraph

Article in BMC medical ethics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Towards trust-based governance of health data research.Medicine, health care, and philosophy · 2023
    Article
  11. Review
  12. Article
  13. Observational
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Dylan W de LangeDepartment of Intensive Care Medicine, University Medical Center, University Utrecht, Heidelberglaan 100, 3584, CX, Utrecht, The Netherlands. d.w.delange@umcutrecht.nl.ORCID 0000-0002-0191-7270
Bertrand GuidetHôpitaux de Paris, Hôpital Saint-Antoine, Service de Réanimation Médicale, 75012, Paris, France.
Finn H AndersenDepartment of Anesthesia and Intensive Care, Møre and Romsdal Health Trust, Ålesund Hospital, Ålesund, Norway.
Antonio ArtigasDepartment of Intensive Care Medicine, CIBER Enfermedades Respiratorias, Corporacion Sanitaria Universitaria Parc Tauli, Autonomous University of Barcelona, Sabadell, Spain.
Guidio BertoliniLaboratory of Clinical Epidemiology, GiViTI Coordinating Center, department of Public Health, IRCCS - "Mario Negri" Institute for Pharmacological Research, Ranica (Bergamo), Italy.
Rui MorenoUnidade de Cuidados Intensivos Neurocríticos, Hospital de São José, Centro Hospitalar de Lisboa Central, Lisbon, Portugal.
Steffen ChristensenDepartment of Anaesthesia and Intensive Care Medicine, Aarhus University Hospital, Aarhus, Denmark.
Maurizio CecconiDepartment Anaesthesia and Intensive Care Units, IRCCS Istituto Clinico Humanitas, Humanitas University, Milan, Italy.
Christina Agvald-OhmanDepartment of Anaesthesiology and Intensive Care, Department of Clinical Intervention and Technology, Karolinska University Hospital, Huddinge, Sweden.
Primoz GradisekClinical Department of Anaesthesiology and Intensive Therapy, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Christian JungDivision of Cardiology, Pulmonology and Vascular Medicine, University Hospital Düsseldorf, Heinrich-Heine-University, Düsseldorf, Germany.
Brian J MarshDepartment of Surgery, Mater Misericordiae University Hospital, Dublin, Ireland.
Sandra OeyenDepartment of Intensive Care Medicine, Ghent University Hospital, Ghent, Belgium.
Bernardo Bollen PintoDivision of Anaesthesiology, Department of Anaesthesiology, Clinical Pharmacology and Intensive Care (APSI), Geneva University Hospitals, Geneva, Switzerland.
Wojciech SzczeklikDivision of Intensive Care and Perioperative Medicine, 2nd Department of Medicine, Jagiellonian University Medical College, Krakow, Poland.
Ximena WatsonIntensive Care, Kingston Hospital, Kingston, UK.
Tilemachos ZafeiridisIntensive Care Unit, General Hospital of Larissa, Larissa, Greece.
Hans FlaattenDepartment of Anaesthesia, Haukeland University Hospital, University of Bergen, Bergen, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEthical approval (EA) must be obtained before medical research can start. We describe the differences in EA for an pseudonymous, non-interventional, observational European study.

methodsSixteen European national coordinators (NCs) of the international study on very old intensive care patients answered an online questionnaire concerning their experience getting EA.

resultsN = 8/16 of the NCs could apply at one single national ethical committee (EC), while the others had to apply to various regional ECs and/or individual hospital institutional research boards (IRBs). The time between applying for EA and the first decision varied between 7 days and 300 days. In 9/16 informed consent from the patient was not deemed necessary; in 7/16 informed consent was required from the patient or relatives. The upload of coded data to a central database required additional information in 14/16. In 4/16 the NCs had to ask separate approval to keep a subject identification code list to de-pseudonymize the patients if questions would occur. Only 2/16 of the NCs agreed that informed consent was necessary for this observational study. Overall, 6/16 of the NCs were satisfied with the entire process and 8/16 were (very) unsatisfied. 11/16 would welcome a European central EC that would judge observational studies for all European countries. DISCUSSION: Variations in the process and prolonged time needed to get EA for observational studies hampers inclusion of patients in some European countries. This might have a negative influence on the external validity. Further harmonization of ethical approval process across Europe is welcomed for low-risk observational studies.

conclusionGetting ethical approval for low-risk, non-interventional, observational studies varies enormously across European countries.

Indexed as

Ethical ReviewEthics Committees, ResearchEuropeHumansInformed ConsentObservational Studies as TopicSurveys and QuestionnairesTime Factors

Identifiers

PMID31159853
PMCPMC6547492

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.